Kim Commins-Tzoumakas, J.D., was appointed as the Chief Executive Officer in 2018, responsible for all U.S. and International operations.
Blake Howard has over 20 years of senior financial management experience in publicly held and private equity sponsored companies. As Interim Chief Financial Officer, Mr. Howard provides oversight of regional operations, business services and finance.
Odette Bolano joined 21st Century Oncology in 2018, serving as the Chief Operating Officer for U.S. and International Operations. In this role, Ms. Bolano generates and advances corporate strategic projects, working with other members of the leadership team to ensure the success of strategic initiatives.
Dr. Constantine “Connie” Mantz joined 21st Century Oncology in 2000 and has served in his current capacity as Chief Policy Officer since February 2018 and formerly as Chief Medical Officer and Senior Vice President of Clinical Operations. Dr. Mantz is Board Certified in Radiation Oncology by the American Board of Radiology. At 21st Century Oncology, as an area expert, he leads the company’s focus on the study and treatment of prostate and breast cancer.
Dr. Arie Dosoretz joined 21st Century Oncology in 2015 and has served in his current capacity of Chief of Clinical Operations and Quality since February 2018. In this role, he is devoted to quality initiatives for the company and works closely with the operations team to ensure a patient and physician focus in all operational decisions. He continues to provide clinical services in addition to this administrative role.
Gustavo Olivera is 21st Century Oncology's Chief Technical Officer. In this role, he oversees all aspects of the physics department and ensures adherence to Medical Physics quality requirements, accreditation requirements and administration, physics vendor management, and applicable state and federal laws. He is also responsible for strategic development of the physics/technology department.
Gabe de Paz leads the Information Technology team and oversees the Company's information strategy and operations. Mr. de Paz has more than 24 years of experience in information technology within the healthcare industry.
Barry Axelrod leads the information security team and oversees the company’s information security risk management program, which is focused on protecting the confidentiality, integrity, and availability of all information systems and data.
Steven Graham joined the 21st Century Oncology team in 2017 as Chief Accounting Officer. In this role, Mr. Graham is responsible for the core accounting, finance, and business functions. His background includes full responsibility for geographically-dispersed, broad-brand accounting and compliance teams.
Betta Sherman leads the corporate and regional compliance team, implementing a program that is consistent with guidelines issued by the Office of Inspector General of the U.S. Department of Health and Human Services. Ms. Sherman has been working with 21st Century Oncology since 2015.
Juli Wessel joined 21st Century Oncology in 2017 as the Chief Privacy Officer. In this role, she is responsible for the development, implementation, and maintenance of privacy policies and training. She manages the company’s privacy monitoring program, including investigating and tracking privacy incidents, and ensuring compliance with federal and state breach notification rules. She also oversees the company’s compliance with use and disclosure requirements and patients’ rights with respect to protected health information (PHI).
Amy Garrigues serves as Chief Legal Officer and Executive Vice President of the Company. Prior to joining the Company, she was the Managing Partner of the Raleigh office of a national health care law firm and a member of the firm’s Board of Directors.
Mark Zickel joined the 21st Century Oncology team in 2017 as Senior Vice President of Payer Contracting and Relations. Mr. Zickel is responsible for managing relationships with national, regional and local payers across the United States.
Kristin Meyer joined 21st Century Oncology in 2008. In her current role, she provides oversight of the development of talent management, policy development, and the development of patient and employee-focused corporate culture initiatives.